免疫疗法生物标志物 2016：突破障碍。

Immunotherapy biomarkers 2016: overcoming the barriers.

机构信息

Genitourinary Malignancies Branch, Center for Cancer Research, NCI, 10 Center Dr., 13 N240, Bethesda, MD, 20892, USA.

Vaccine Branch, Center for Cancer Research, 41 Medlars Dr, Bldg 41 Rm D702D, Bethesda, MD, 20892, USA.

出版信息

J Immunother Cancer. 2017 Mar 21;5(1):29. doi: 10.1186/s40425-017-0225-6.

DOI:10.1186/s40425-017-0225-6
PMID:28653584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5359902/
Abstract

This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

摘要

本报告总结了于 2016 年 4 月 1 日在马里兰州贝塞斯达的美国国立卫生研究院举行的研讨会“免疫治疗生物标志物 2016：克服障碍”。该研讨会由癌症免疫治疗学会（SITC）和美国国立癌症研究所（NCI）共同主办，重点讨论了新兴的免疫治疗生物标志物、新技术、进一步进展的当前障碍以及推进生物标志物开发领域的建议。

相似文献

[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]

引用本文的文献

[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]

本文引用的文献

[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索